Terms: = Uterine cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6
13 results:
1. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against Cervical cancer.
Ahmad S; Sayeed S; Bano N; Sheikh K; Raza K
J Biomol Struct Dyn; 2023 Nov; 41(19):9770-9786. PubMed ID: 36379678
[TBL] [Abstract] [Full Text] [Related]
2. Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia.
Chen M; Wang H; Liang Y; Hu M; Li L
BMC Cancer; 2020 Sep; 20(1):926. PubMed ID: 32993576
[TBL] [Abstract] [Full Text] [Related]
3. tgfbr2 Regulates Hedgehog Pathway and Cervical cancer Cell Proliferation and Migration by Mediating SMAD4.
Yuan J; Yi K; Yang L
J Proteome Res; 2020 Aug; 19(8):3377-3385. PubMed ID: 32628850
[TBL] [Abstract] [Full Text] [Related]
4. Identification and characterization of tumorigenic circular RNAs in cervical cancer.
Huang H; Chen YF; Du X; Zhang C
Cell Signal; 2020 Sep; 73():109669. PubMed ID: 32423867
[TBL] [Abstract] [Full Text] [Related]
5. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.
Xu Q; Chen C; Liu B; Lin Y; Zheng P; Zhou D; Xie Y; Lin Y; Guo C; Liu J; Li L
Oncol Rep; 2020 Jan; 43(1):41-54. PubMed ID: 31661139
[TBL] [Abstract] [Full Text] [Related]
6. Activin-like kinase 5 (ALK5) inactivation in the mouse uterus results in metastatic endometrial carcinoma.
Monsivais D; Peng J; Kang Y; Matzuk MM
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3883-3892. PubMed ID: 30655341
[TBL] [Abstract] [Full Text] [Related]
7. MiR-17-5p promotes cervical cancer cell proliferation and metastasis by targeting transforming growth factor-β receptor 2.
Cai N; Hu L; Xie Y; Gao JH; Zhai W; Wang L; Jin QJ; Qin CY; Qiang R
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1899-1906. PubMed ID: 29687841
[TBL] [Abstract] [Full Text] [Related]
8. Concomitant underexpression of tgfbr2 and overexpression of hTERT are associated with poor prognosis in cervical cancer.
Yang H; Zhang H; Zhong Y; Wang Q; Yang L; Kang H; Gao X; Yu H; Xie C; Zhou F; Zhou Y
Sci Rep; 2017 Feb; 7():41670. PubMed ID: 28195144
[TBL] [Abstract] [Full Text] [Related]
9. Integrated genomic and molecular characterization of cervical cancer.
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Nature; 2017 Mar; 543(7645):378-384. PubMed ID: 28112728
[TBL] [Abstract] [Full Text] [Related]
10. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.
Wei T; Geiser AG; Qian HR; Su C; Helvering LM; Kulkarini NH; Shou J; N'Cho M; Bryant HU; Onyia JE
BMC Womens Health; 2007 Apr; 7():5. PubMed ID: 17407572
[TBL] [Abstract] [Full Text] [Related]
11. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
[TBL] [Abstract] [Full Text] [Related]
12. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review.
Arslan AA; Gold LI; Mittal K; Suen TC; Belitskaya-Levy I; Tang MS; Toniolo P
Hum Reprod; 2005 Apr; 20(4):852-63. PubMed ID: 15705628
[TBL] [Abstract] [Full Text] [Related]
13. Decreased expression of human papillomavirus E2 protein and transforming growth factor-beta1 in human cervical neoplasia as an early marker in carcinogenesis.
Torng PL; Chan WY; Lin CT; Huang SC
J Surg Oncol; 2003 Sep; 84(1):17-23. PubMed ID: 12949986
[TBL] [Abstract] [Full Text] [Related]
